podcast

Market Access

Smoothing a contract pathway through uncertainty: In convers...

Today's podcast with Entity Risk's Neal Masia includes insights on the 340B Program, PBMs, and risk-based contracts.

Digital

Frontiers Health limited series podcast, Roberto Ascione

FH25: On the future of health, with Frontiers Health Chairma...

In the final episode of our special Frontiers Health limited series, conference Chairman Roberto Ascione discusses his favourite moments and insights.

R&D

pharmaphorum podcast Episode 209a, Gene Mack

Allosteric small molecule therapies in PD, with Gene Mack

pharmaphorum looks back to a conversation with Gain Therapeutics' CEO Gene Mack earlier in the year, on research in the Parkinson's disease space.

Digital

FH25: Jessica DaMassa on hosting, hype, and health innovatio...

In a new episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with WTF Health founder and event emcee, Jessica DaMassa

Digital

pharmaphorum podcast Episode 208a, Dr Jay Anders

Improving ROI on AI investments and data quality, with Dr Ja...

Dr Jay Anders, chief medical officer for Medicomp Systems, discusses why he believes that the only way to solve AI ROI issues is to solve data quality

R&D